Mechanism
Nectin-4 (PVRL4)
Assets acting on this target.
- Class
- Nectin-4-targeting radiopharmaceutical (actinium-225 conjugate)
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT07020117
Mechanism
Assets acting on this target.
1 of 1 assets